Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

An innovative treatment based on harmine and alpha cells could transform diabetes treatment and reduce insulin dependence ...

The US Food and Drug Administration (FDA) has issued warning letters to four companies selling unapproved glucagon-like ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Blood sugar and insulin levels also depend on the vagus nerve. As blood sugar levels rise, the vagus nerve stimulates the ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

The US data suggest that the South has seen the greatest shifts, and the highest rate of GLP-1 prescribing per capita.

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...

Shares of Viking Therapeutics (VKTX) are down $2.70, or 6%, to $44.00 in pre-market trading following Merck (MRK) and Chinese biopharmaceutical ...

Polyphenols are a diverse group of compounds that contribute to the flavor and health benefits of foods like green tea, ...

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...